OncoTargets and Therapy
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 2.4 | Q3 | 36.0% | 0.800 | Q2 | 77.3% |
| 2024 | 2.8 | Q2 | 51.2% | 0.818 | Q2 | 78.6% |
| 2023 | 2.7 | Q3 | 46.0% | 0.810 | Q2 | 80.1% |
| 2022 | 4.0 | Q2 | 61.9% | 0.836 | Q2 | 81.7% |
| 2021 | 4.3 | Q3 | 59.2% | 0.811 | Q2 | 81.5% |
| 2020 | — | — | 1.054 | Q2 | 86.4% | |
| 2019 | — | — | 0.954 | Q2 | 84.6% | |
| 2018 | — | — | 0.986 | Q2 | 83.8% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
ISSN
1178-6930
country
NZcoverage
2009-2026